New York State Common Retirement Fund
CTXR icon

New York State Common Retirement Fund’s Citius Pharmaceuticals CTXR Stock Holding History

New York State Common Retirement Fund’s Portfolio CTXR Stock Details CTXR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-45
Closed -$662 – 3218
2024
Q2 		$662 Sell
45
-3,075
-99% -$55.1K ﹤0.01% 3314
2024
Q1 		$70K Hold
3,120
– – ﹤0.01% 2877
2023
Q4 		$59K Sell
3,120
-14
-0.4% -$266 ﹤0.01% 2945
2023
Q3 		$53.6K Buy
3,134
+54
+2% +$1.28K ﹤0.01% 3003
2023
Q2 		$92.4K Buy
+3,080
New +$101K ﹤0.01% 2924
2022
Q3 		– Sell
-37
Closed -$1K – 3309
2022
Q2 		$1K Sell
37
-2,041
-98% -$56K ﹤0.01% 3336
2022
Q1 		$93K Hold
2,078
– – ﹤0.01% 3035
2021
Q4 		$80K Sell
2,078
-7
-0.3% -$318 ﹤0.01% 3133
2021
Q3 		$106K Sell
2,085
-1,807
-46% -$90.7K ﹤0.01% 3123
2021
Q2 		$339K Buy
+3,892
New +$234K ﹤0.01% 2795

Other funds holding CTXR

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CCC
Chelsea Counsel Company Los Angeles, California $225M AUM 45.99% 1-Year Est. Return

New York State Common Retirement Fund's CTXR Position: Q3 2024 in Review

New York State Common Retirement Fund sold out of Citius Pharmaceuticals (CTXR) in Q3 2024, closing a stake of 45 shares — an estimated $662 sold.

New York State Common Retirement Fund first reported a position in CTXR in Q2 2021 and held it in 10 quarters. The position peaked at $339K in Q2 2021. 57 funds tracked by Wall St. Rank hold CTXR as of Q3 2024.

  • New York State Common Retirement Fund reported no remaining Citius Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • New York State Common Retirement Fund sold 45 Citius Pharmaceuticals shares in Q3 2024, an estimated $662.
  • New York State Common Retirement Fund first reported a position in Citius Pharmaceuticals in Q2 2021 and held it in 10 quarters.
  • New York State Common Retirement Fund's Citius Pharmaceuticals position peaked at $339K in Q2 2021.
  • 57 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q3 2024.

Based on New York State Common Retirement Fund's 13F filing for Q3 2024, filed 28 Oct 2024.